Results per Page:
‘I can’t remember the last time I saw someone with bad gut GVHD’: BMT expert reflects on recent lifesaving successes
Fred Hutch bone marrow transplant and GVHD expert Dr. Geoffrey Hill explains how a new approach has changed the BMT landscape, where research is headed next
Novel drug regimen reduces risks of graft-versus-host disease
From the Hill Group, Translational Science and Therapeutics Division in collaboration with Alfred Health and Monash University
Going beneath the skin: A closer look at serositis in cGVHD
From the Lee Lab, Clinical Research Division
Donor factors influence success of fecal microbiota transplant
From the Rashidi Group, Pathogen Associated Malignancies Program of the Cancer Consortium and Clinical Research Division
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
Graft-versus-host disease outcomes improving for all Fred Hutch patients
From the Long-Term Follow-Up Research Group, Clinical Research Division
Secret to tamping down GVHD may lie in microbial genetics
Preclinical bone marrow transplant study shows donor immune cells that target recipient microbiome can influence GVHD severity
All eyes on IL-6 when it comes to CMV reactivation after bone marrow transplantation
From the Hill Lab in Translational Sciences and Therapeutics Division
Aplastic anemia diagnosis took business strategy manager by surprise
Transplant replaced his failing bone marrow with healthy cells
Caregivers know compassion is critical; staying organized is, too
One woman shares tips on caring for a spouse going through blood cancer treatment
Pre-transplant microbiome sets the stage for GVHD
Preclinical findings highlight bacterial groups that influence GVHD risk
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Dispatches from the microbial frontier of cancer research
Hutch scientists aim high by way of the lowly microorganisms that call us home
Commensals turn pathogenic in graft-vs-host disease
From the University of Michigan and the Fredricks Lab, Vaccine and Infectious Disease Division
Mystery solved: How graft-vs.-host disease starts in the gut
Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it
How a phone call helped shape the field of bone marrow transplant
A lifesaving new leukemia treatment was harming some patients’ digestive organs, and no one really understood why. So, over 40 years, Dr. George McDonald helped fill in the gaps.